课题基金 / 基金详情

项目摘要

项目成果

GEROLD BEPLER的其他基金

相似基金

相关文献

中文摘要
翻译
KCI高级领导层由三名基础科学科学副中心主任(ACD)组成 (魏禅伟博士)、临床科学(安东尼·希尔兹博士)和人口科学(Terrance Albrecht博士)。 增加了一个新的高级领导职位,核心科学总监(弗雷德·米勒博士), 负责对癌症中心核心的监督和科学领导。他们都是由 研究管理协会(康斯坦斯·克莱贝克女士),由副中心监督 主任安·施瓦茨博士。作为卡马诺斯癌症研究所的总裁、首席执行官和中心主任, Gerold Bepler对KCI所有资源的行政和财务管理负有最终责任, 包括预算、人员和教职员工任命以及空间和设备分配。 这个团队的主要职责是确保中心的所有资源都得到最佳利用 部署以促进杰出科学以及方案内和方案间的发展 互动。这些广泛的领域,每个领域都由更具体的调查兴趣组成,定义了角色 高级领导人,以确保圆满完成研究所更广泛的科学目标 通过活跃的个人项目组合。美国疾病控制与预防中心通过参加这样的战略委员会 作为ACD委员会、主席委员会和科学领导委员会,支持正在进行的 关于资源分配的讨论和辩论。此外,科学ACD还监督着一项 每年75万美元的可自由支配资金,用于支持试点研究、新的博士后计划和 年内的招聘机会。需要高级领导层的支持:贝普勒博士(50% 努力,25%的资金),A.施瓦茨博士(25%的努力,10%的资金),魏博士(10%的努力和资金), 希尔兹(10%的努力和资金),阿尔布雷希特博士(10%的努力和资金),克莱贝克女士(10%的努力和资金) 资金)和F.Miller博士(25%的努力和资金)。其中两个科学ACD也作为计划 这些努力的领导人和资金是在其他地方要求的,为克莱贝克女士提供的资金也是如此 研究管理署。
英文摘要
KCI Senior Leadership is composed of three scientific Associate Center Directors (ACDs) for Basic Sciences (Dr. Wei-Zen Wei), Clinical Sciences (Dr. Anthony Shields) and Population Sciences (Dr. Terrance Albrecht). A new senior leadership position, Scientific Director of Cores, has been added (Dr. Fred Miller) with responsibility for oversight and scientific leadership for the Cancer Center Cores. They are all supported by an ACD for Research Administration (Ms. Constance Claybaker) and overseen by the Deputy Center Director, Dr. Ann Schwartz. As President, CEO, and Center Director of the Karmanos Cancer Institute, Dr. Gerold Bepler bears ultimate responsibity for the administration and fiscal management of all KCI resources, including budgeting, personnel and faculty appointments, and space and equipment allocations. The primary responsibility of this team lies in ensuring that all of the Center's resources are optimally deployed to enhance the development of outstanding science as well as intra- and inter-programmatic interactions. These broad areas, each composed of more specific interests for investigation, define the role of the Senior Leaders to ensure the successful completion of broader scientific goals of the Institution through an active portfolio of individual Programs. The ACDs, by participating in such strategic committees as the ACD Committee, President's Committee, and Scientific Leadership Council, support ongoing discussions and debates about the allocation of resources. In addition, the scientific ACDs, oversee a discretionary fund of $750,000 annually to support pilot studies, the new post-doctoral program and recruitment opportunities during the year. Support is requested for Senior Leadership: Dr. Bepler (50% effort, 25% funding), Dr. A. Schwartz (25% effort, 10% funding), Dr. Wei (10% effort and funding), Dr. Shields (10% effort and funding), Dr. Albrecht (10% effort and funding), Ms. Claybaker (10% effort and funding) and Dr. F. Miller (25% effort and funding). Two of the scientific ACDs also serve as Program Leaders and funds for those efforts are requested elsewhere as is the funding for Ms. Claybaker as ACD of Research Administration.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developmental Research Program
  • 批准号:
    10289607
  • 项目类别:
  • 资助金额:
    $8.42万
  • 财政年份:
    2021
  • 负责人:
    GEROLD BEPLER
  • 依托单位:
ETCTN Early Drug Development Opportunity Leadership program administrative supplement to Cancer Center Support Grant
  • 批准号:
    10363981
  • 项目类别:
  • 资助金额:
    $12.5万
  • 财政年份:
    2021
  • 负责人:
    GEROLD BEPLER
  • 依托单位:
Reducing Cancer Health Disparities in Detroit
  • 批准号:
    10289601
  • 项目类别:
  • 资助金额:
    $99.34万
  • 财政年份:
    2021
  • 负责人:
    GEROLD BEPLER
  • 依托单位:
Developmental Research Program
  • 批准号:
    10684289
  • 项目类别:
  • 资助金额:
    $8.12万
  • 财政年份:
    2021
  • 负责人:
    GEROLD BEPLER
  • 依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
  • 批准号:
    2021JJ40433
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2021
  • 负责人:
    孙磊
  • 依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
  • 批准号:
    32001603
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    段真珍
  • 依托单位:
AREA国际经济模型的移植.改进和应用
  • 批准号:
    18870435
  • 项目类别:
    面上项目
  • 资助金额:
    2.0万元
  • 批准年份:
    1988
  • 负责人:
    史树中
  • 依托单位: